Výsledky vyhledávání

Prevention of postmenopausal bone loss by rectal calcitonin

Autor: Rita Deroisy, Paul Franchimont, I. Jupsin, Jean-Yves Reginster, Nathalie Franchimont, I. Biquet

Publikováno v: Calcified Tissue International. 56:539-542

A group (150) of healthy women, who had been menopausal for less than 5 years and who had never received any form of treatment to prevent bone loss were entered into a randomized, controlled study comprising three arms. They were randomly allocated t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eebd355ce9d75d682ba9bfb1010700ad
https://doi.org/10.1007/bf00298586

Zobrazit plný text záznamu

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss

Autor: Brigitte Zegels, Marie P. Lecart, I. Jupsin, Nathalie Sarlet, Rita Deroisy, Jean Y. Reginster, Paul Franchimont, Marc de Longueville

Publikováno v: The American Journal of Medicine. 98:452-458

Nasal administration of salmon calcitonin (SCT) has been suggested for preventing trabecular bone loss during the first years following the menopause, but no conclusive evidence has appeared about the minimal effective dose. Since nasal calcitonin is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbd9a6ba3b4526269be483d03a0ed1da
https://doi.org/10.1016/s0002-9343(99)80344-1

Zobrazit plný text záznamu

Strontium ranelate: a new paradigm in the treatment of osteoporosis

Autor: Jean-Yves Reginster, I. Jupsin, Rita Deroisy

Publikováno v: Drugs of today (Barcelona, Spain : 1998). 39(2)

Not one of the currently available medications has, so far, unequivocally demonstrated its ability to fully prevent the occurrence of new vertebral or peripheral osteoporotic fractures once osteoporosis is established. Therefore, several new therapie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab1e1b6d18cb94178bcf936894160a36
https://pubmed.ncbi.nlm.nih.gov/12698204

Zobrazit plný text záznamu

Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial

Autor: I. Jupsin, Maxime Dougados, Rita Deroisy, Christian Roux, J Colette, Jacques Reginster

Publikováno v: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 13(12)

Early postmenopausal women (n = 160) were randomised to receive placebo or strontium ranelate (SR) 125 mg/day, 500 mg/day or 1 g/day for 2 years (40 participants per group). All participants received calcium 500 mg/day. The primary efficacy parameter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b6e73bf17dedee51ad93f8744e87d0
https://pubmed.ncbi.nlm.nih.gov/12459934

Zobrazit plný text záznamu

Administration of a supplement containing both calcium and vitamin D is more effective than calcium alone to reduce secondary hyperparathyroidism in postmenopausal women with low 25(OH)vitamin D circulating levels

Autor: J. Collette, I. Jupsin, R. Deroisy, Adelin Albert, Jean-Yves Reginster

Publikováno v: Aging clinical and experimental research. 14(1)

Background and aims: Supplementation of postmenopausal women with calcium alone or calcium-vitamin D association was suggested to have positive effects on bone turnover and bone density, as well as to lower fracture incidence. The beneficial effect a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84f929dd0ec4a1df1c30970243d5395c
https://pubmed.ncbi.nlm.nih.gov/12027147

Zobrazit plný text záznamu

A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium

Autor: I. Biquet, I. Jupsin, Paul Franchimont, L Meurmans, Rita Deroisy, Jean-Yves Reginster, Adelin Albert

Publikováno v: European journal of clinical investigation. 24(8)

The aim of this paper was to evaluate the long-term (5 years) efficacy of nasal salmon calcitonin in prevention of trabecular postmenopausal bone loss, which was a follow-up of a previously published study (3 years); a randomized, controlled group co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04df004ef0b76eb574148e06c6a5743
https://pubmed.ncbi.nlm.nih.gov/7982445

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání